Drug intelligence / Profile preview

Riketron N

Development stage
Unknown
Lead developer
aniMedica
Modality
Small Molecules
Administration
Intramuscular, Intravenous
01

Overview

**Riketron N** is a veterinary fixed-dose injectable antibacterial product containing sulfadimidine sodium and trimethoprim. Sulfadimidine inhibits bacterial dihydropteroate synthase and trimethoprim inhibits bacterial dihydrofolate reductase, producing sequential blockade of microbial tetrahydrofolate synthesis and a synergistic bactericidal effect. It is authorized for intramuscular or intravenous treatment of susceptible bacterial infections in cattle, horses, and pigs, including infections of the respiratory, gastrointestinal, urogenital, skin, and claw systems. The product is marketed as a 200 mg/ml sulfadimidine sodium plus 40 mg/ml trimethoprim solution for injection.

Brand names
Riketron N
02

Targets

AR (Adrenergic receptors)Cyp (Cyclophilin family)Nicotinamide adenine dinucleotide biosynthesis pathway (NAD biosynthesis pathway)Vitamin K-dependent gamma-carboxylation pathway

Beyond the preview

Go deeper on Riketron N.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Riketron N.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call